Day: December 7, 2020

ALBUQUERQUE, N.M., Dec. 07, 2020 (GLOBE NEWSWIRE) — Array Technologies, Inc. (NASDAQ: ARRY) (the “Company”) today announced the closing of the previously announced secondary offering by a parent entity of the Company controlled by Oaktree Capital (the “Selling Stockholder”). The offering consisted of 36,656,250 shares of the Company’s common stock sold by the Selling Stockholder, which included 4,781,250 shares of the common stock following the exercise in full of the underwriters’ option to purchase additional shares of the Company’s common stock from the Selling Stockholder, at the public offering price of $35.00 per share. The Company did not receive any of the proceeds from the sale of shares by the Selling Stockholder. The Company’s common stock is listed on the Nasdaq Global Market under the symbol “ARRY.”Goldman Sachs...

PLEASANTON, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) — Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced that Drew Davies, Executive Vice President and Chief Financial Officer will present at the 13th Annual LD Micro Conference. Mr. Davies is scheduled to present on Monday, December 14th at 12:40 p.m. Eastern Time (9:40 a.m. Pacific Time).About Natus Medical IncorporatedNatus is a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages.Additional information about Natus Medical can be found at www.natus.com.Natus Medical IncorporatedDrew DaviesExecutive...

Hamilton, Bermuda, December 7, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and CNS disorders, today announced that Chairman and CEO Thomas Meyer will present at the 13th Annual LD Micro Main Event investor conference on Tuesday, December 15, 2020, at 10:40 a.m. EST. The event will be webcast live and available via the event homepage https://ve.mysequire.com/.About Auris MedicalAuris Medical is a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and CNS disorders. The Company is focused on the development of intranasal betahistine for the treatment of vertigo (AM-125, in Phase 2) and for the prevention...

BURLINGAME, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc. (“ALX Oncology”) (Nasdaq: ALXO), a clinical-stage immuno-oncology company developing therapies to block the CD47 checkpoint pathway, today announced that it has commenced an underwritten public offering of 2,000,000 shares of its common stock. All of the shares in the proposed offering will be sold by ALX Oncology. In addition, ALX Oncology expects to grant the underwriters a 30-day option to purchase up to an additional 300,000 shares of its common stock in the offering. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the proposed offering may be completed, or as to the actual size or terms of the offering.Jefferies, Credit Suisse, and Piper Sandler are acting as joint book-running...

CHICAGO, Dec. 07, 2020 (GLOBE NEWSWIRE) — Oil-Dri Corporation of America (NYSE: ODC), producer and marketer of sorbent mineral products, today announced results for its first quarter of fiscal year 2021.Daniel S. Jaffee, President and Chief Executive Officer, stated, “Coming off of a year with record sales and net income, I am extremely pleased that our momentum has continued into the first quarter of fiscal 2021. These solid results demonstrate how we are succeeding in our mission to Create Value from Sorbent Minerals as we align with a diversified customer base spanning many different industries and countries. Revenues from cat litter remain strong both domestically and internationally, as more consumers embrace the value of our lightweight litter. We achieved sales gains within our Business to Business (“B2B”) Products Group...

SOUTH SAN FRANCISCO, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced that it will host a conference call and webcast to review the status and provide a clinical update for its three most advanced TriTAC® programs. The discussion will be focused on HPN424 for the treatment of metastatic castration resistant prostate cancer, HPN536 initially in development for ovarian and pancreatic cancer and mesothelioma, and HPN217 for relapsed/refractory multiple myeloma.The live call/webcast will take place at 8 a.m. ET / 5 a.m. PT on December 8, 2020 and can be accessed by dialing (866) 951-6894 for domestic callers and (409) 216-0624 for international callers with conference ID code number 1388395. A webcast...

SOUTH SAN FRANCISCO, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) — Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD), announced today that it will provide an end-of-year business update on veverimer’s development program, regulatory status and patent protection.Tricida will host a conference call and webcast at 4:30 pm Eastern Time on December 8, 2020. The webcast, including slides, or conference call may be accessed as follows:A replay of the webcast will be available on Tricida’s website approximately two hours following the completion of the call and will be available for up to 90 days following the...

TUSTIN, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced the appointment of Jeanne Thoma as an independent member of the company’s board of directors. Ms. Thoma is a seasoned pharmaceutical industry executive with more than 30 years of experience spanning product development and commercialization, as well as operations and supply chain management.“On behalf of the entire board, I am delighted to welcome Ms. Thoma with her extensive pharmaceutical industry expertise to the Avid board of directors,” said Joseph Carleone, Ph.D., Avid’s chairman of the...

 –  Rochester, New York Insurance brokerage firm will be acquired by SDN Insurance Agency, Financial Institutions’ insurance subsidiary–  Landmark principals Kelly M. Shea and Christopher K. Shea will remain with SDN Insurance to lead Rochester operations and manage Landmark accountsWARSAW, N.Y., Dec. 07, 2020 (GLOBE NEWSWIRE) — Financial Institutions, Inc. (NASDAQ:FISI) (the “Company”), parent company of Five Star Bank (the “Bank”), SDN Insurance Agency, LLC (“SDN”), Courier Capital, LLC (“Courier Capital”) and HNP Capital, LLC (“HNP Capital”), today announced a definitive agreement for the acquisition of the assets of Landmark Group (“Landmark”) by the Company’s insurance subsidiary SDN.A staple of the Rochester community since 1984, Landmark is an independent insurance brokerage firm delivering insurance, surety and...